Bigfoot Biomedical said today that it inked a commercial supply deal to include Owen Mumford‘s Pentips line of pen needles with Bigfoot’s injection system subscription bundles.
Milpitas, Calif.-based Bigfoot is working on monthly subscription packages for people with insulin-requiring diabetes. The company said it selected Owen Mumford’s pen needle because of the needle’s compatibility with all disposable insulin pens and availability in popular lengths and gauges.
Get the full story at our sister site, Drug Delivery Business News.
The post Bigfoot Biomedical, Owen Mumford ink deal for pen needles appeared first on MassDevice.